To determine the tumorigenic role of YBX1 in ESCC cells, we utilized YBX1‐specific shRNAs and an YBX1‐overexpressing plasmid to efficiently knockdown and overexpress YBX1, respectively (Figure 2A–C). This evidence concerns the gene YBX1 and esophageal squamous cell carcinoma.